WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016

Mar 15, 2016

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-02-23

Reporting Person: Flynn Karen (President, Pharma Pckg Systems)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-23	Common Stock	A	3914.0000	$59.6400	Acquired	27965.7333	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-23	Stock Option (Right to Buy)	$59.6400	A	30356.0000	Acquired	2026-02-23	Common Stock (30356.0000)	Direct

Footnotes

F1: Original filing contained incorrect number of options granted, correct number now reflected on this report